Interestingly, some p53 mutations, such as p.R248W and p.R249S, have been surprisingly associated to a ‘gain-of-function’ (GOF) promoting cancer malignancy (invasion and metastasis), genetic heterogeneity and chemoresistance [112,113]. This evidence concerns the gene TP53 and cancer.